Cite
HARVARD Citation
Freyer, C. et al. (2022). Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. Leukemia & lymphoma. 63 (8), pp. 1925-1933. [Online].